CNS PHARMACEUTICALS INC (CNSP)

US18978H2013 - Common Stock

0.2182  +0 (+0.09%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
0.000.000.000.000.00
Operating Expenses
18.87M15.27M14.49M9.45M3.83M
Research and Development
14.10M9.30M9.81M5.06M1.85M
Selling, General, and Administrative Expenses
4.77M5.97M4.68M4.39M1.98M
Operating Income
-18.87M-15.27M-14.49M-9.45M-3.83M
Interest Income/Expense
13.88K-10.00K-10.00K0.00-40.00K
Other Income/Expense
N/AN/AN/AN/A0.00
Non Recurring Items
N/AN/AN/AN/A0.00
Income Before Taxes
-18.85M-15.27M-14.50M-9.46M-3.88M
Income Tax
N/AN/AN/AN/A0.00
Net Income
-18.85M-15.27M-14.50M-9.46M-3.88M
EBITDA
-18.86M-15.26M-14.48M-9.44MN/A
 
Per Share Data
EPS Diluted Total Ops
-5.00-11.22-16.47-11.82-8.62
Non GAAP EPS
N/AN/A-16.20-17.10N/A
 
Statistics

All data in USD

Charts